|Food||Highs & Lows||In the News||Insulin & Pumps|
|Men's Issues||Real Life||Relationships||Type 1|
|Type 2||Women's Issues||Oral Meds||Technology|
Chris Stocker was diagnosed with Type 1 Diabetes in April of 2004 when he was admitted into the ER with a blood glucose of 858. Since diagnosis, Chris has gone on to write The Life of a Diabetic, a blog about living with type 1 diabetes. Chris is an insulin pump and CGM user and a lover of diabetes technology. Chris is also President, CEO of an online marketing company that he started in 2009. Chris is also a full time husband and father.
IBM is reinventing itself with its development of the Watson Health unit and its venture into the Health Care Industry. The Watson computer is capable of understanding the English language, it can gather and learn from data at an up-to-date-speed, and it is capable of storing all of the data in t
Google is Getting Serious about Sensor Technology by Acquiring Patent for Glucose-Sensing Contact Lens
Google recently received a patent for a new innovative contact lens that will be designed to monitor user’s glucose levels. The patent was applied for back in September of 2012 and was eventually granted on March 24th of this year. The patent, discovered by WebProNews, does not specifically refle
Pharmaceutical company Merck and its partners are introducing a new nanotechnology that could minimize the need to check insulin levels and conduct daily injections. They call it Smart Insulin, and it is making waves in biotechnology and Diabetes research.
In a revolutionary movement, the FDA has given 510(k) approval on Abbott's HbA1C test which is expected to help millions of Americans with Type 1 or 2 diabetes or those at risk.
Abbott's ARCHITECT Clinical Chemistry Hemoglobin A1C (HbA1C) test is a dramatic shift in diabetes diagno
An advisory committee for the Federal Drug Administration recommended approval on a revolutionary product: inhaled insulin. This decision was agreed on 13-1, with only one member claiming that the side effects outweigh the benefits. If followed through, this product, named Afrezza, would allow th
Megan was diagnosed in 2009 with Type I. As an RN, she was familiar with the medical side of her diagnosis; learning to be a good patient on the other hand, was and continues to be the challenge of her day to day life. (Read More)
Michelle Kowalski, a writer, editor and photography hobbiest living in Phoenix, was diagnosed with Type 2 diabetes in February 2005. In January 2008, as part of her quest to start on an insulin pump, Michelle learned that she actually has type 1 diabetes. (Read More)